SelectBIO Adult Stem Cells & Exosome/EV-based Therapeutics Asia 2021 brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas:
- Extracellular Vesicles Produced by Adult Stem Cells and their Functional Activities
- Exosome/EV Engineering
- Exosomes/EV-based Therapeutics Development and Regenerative Medicine
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas:
- Technologies for Isolation and Characterization as Well as High-Volume Production of EVs for Potential Therapeutics Applications
- Exosomes/EVs Derived from Adult Stem Cells and Their Theraeputic/Regenerative Properties
- Role in Cancer and Various Disease Classes -- Regenerative Medicine
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
- Regulatory Landscape in the Use of Exosomes/EVs for Therapeutics
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies.
This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date based on research involving stem cells and stem cell-derived extracellular vesicles (EVs) for clinical utility and regenerative medicine.
All Delegates and Exhibitors Receive Full Access to the Co-Located Conference Track: Cell & Gene Therapy and Cancer Immunotherapy Asia 2021.
Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event. Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.
